Q-Fever Endocarditis and Treatment With the Fluoroquinolones

Archives of Internal Medicine

Volumn 151, Issue 4, 1991, Pages 816-818

  Cacoub, P ^a   Wechsler, B ^a   Chapelon, C ^a   Thibon, M ^a   Godeau, P ^a  

^a NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

AGED; CASE REPORT; DRUG COMBINATION; DRUG EFFICACY; ENDOCARDITIS; HUMAN; LETTER; MALE; PRIORITY JOURNAL; Q FEVER;

AGED; ANTIBIOTICS, COMBINED; CASE REPORT; ENDOCARDITIS, BACTERIAL; HUMAN; MALE; PEFLOXACIN; Q FEVER; RIFAMPIN;

EID: 0025796816     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1991.00400040144041     Document Type: Letter

References (3)

1. Raffy F. Q-fever endocarditis. Lancet. 1989;2:1336-1337.
2. Yearman MR, Mitscher LA, Baca OG. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Antimicrob Agents Chemother. 1987;31:1079-1084.
3. Gudiol F, Pallares R, Carratala J, et al. Randomised double-blind evaluation of ciprofloxacin and doxycyclin for Mediterranean spotted fever. Antimicrob Agents Chemother. 1989;33:987-988.